Postmenopausal Hormone Therapy and Age-Related Maculopathy in Older Women

REFERENCES

• Klein R, Wang Q, Klein B E, Moss S E, Meuer S M. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 1995; 36: 182–191
   PubMed Web of Science ®Google Scholar
• Friedman D S, O'Colmain B J, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004; 122(4)564–572
   PubMed Web of Science ®Google Scholar
• The Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 1992; 110: 1701–1708
   PubMed Web of Science ®Google Scholar
• Klein B E, Klein R, Jensen S C, Ritter L L. Are sex hormones associated with age-related maculopathy in women? The Beaver Dam Eye Study. Trans Am Ophthalmol Soc 1994; 92: 289–95, discussion 295–297
   PubMedGoogle Scholar
• Klein B E, Klein R, Lee K E. Reproductive exposures, incident age-related cataracts, and age-related maculopathy in women: The Beaver Dam Eye Study. Am J Ophthalmol 2000; 130(3)322–326
   PubMed Web of Science ®Google Scholar
• Freeman E E, Munoz B, Bressler S B, West S K. Hormone replacement therapy, reproductive factors, and age-related macular degeneration: The Salisbury Eye Evaluation Project. Ophthalmic Epidemiol 2005; 12(1)37–45
   PubMed Web of Science ®Google Scholar
• Haan M N, Klein R, Klein B E, Deng Y, Blythe L K, Seddon J M, Musch D C, Kuller L H, Hyman L G, Wallace R B. Hormone therapy and age-related macular degeneration: The Women's Health Initiative Sight Exam Study. Arch Ophthalmol 2006; 124(7)988–92
   PubMedGoogle Scholar
• Smith W, Mitchell P, Wang J J. Gender, oestrogen, hormone replacement and age-related macular degeneration: Results from the Blue Mountains Eye Study. Aust N Z J Ophthalmol 1997; 25(Suppl 1)S13–15
   PubMedGoogle Scholar
• Vingerling J R, Dielemans I, Witteman J C, Hofman A, Grobbee D E, de Jong P T. Macular degeneration and early menopause: A case-control study. BMJ 1995; 310(6994)1570–1571
   PubMedGoogle Scholar
• Boekhoorn S S, Vingerling J R, Uitterlinden A G, Van Meurs J B, van Duijn C M, Pols H A, Hofman A, de Jong P T. Estrogen receptor alpha gene polymorphisms associated with incident aging macular disorder. Invest Ophthalmol Vis Sci 2007; 48(3)1012–7
   Google Scholar
• Snow K K, Cote J, Yang W, et al. Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women. Am J Ophthalmol 2002; 134(6)842–848
   PubMed Web of Science ®Google Scholar
• Abramov Y, Borik S, Yahalom C, et al. The effect of hormone therapy on the risk for age-related maculopathy in postmenopausal women. Menopause 2004; 11(1)62–68
   Google Scholar
• Klein R, Klein B E, Jensen S C, Meuer S M. The 5-year incidence and progression of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 1997; 104(1)7–21
   PubMed Web of Science ®Google Scholar
• Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology 2001; 108(4)697–704
   PubMed Web of Science ®Google Scholar
• Mitchell P, Wang J J, Smith W, Leeder S R. Smoking and the 5-year incidence of age-related maculopathy: The Blue Mountains Eye Study. Arch Ophthalmol 2002; 120(10)1357–1363
   PubMedGoogle Scholar
• Delcourt C, Diaz J L, Ponton-Sanchez A, Papoz L. Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liees a l'Age. Arch Ophthalmol 1998; 116(8)1031–1035
   Google Scholar
• Smith W, Mitchell P, Leeder S R. Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol 1996; 114(12)1518–1523
   PubMedGoogle Scholar
• Klein R, Klein B E, Linton K L, DeMets D L. The Beaver Dam Eye Study: The relation of age-related maculopathy to smoking. Am J Epidemiol 1993; 137(2)190–200
   PubMed Web of Science ®Google Scholar
• Vingerling J R, Hofman A, Grobbee D E, de Jong P T. Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol 1996; 114(10)1193–1196
   PubMedGoogle Scholar
• Fraser-Bell S, Wu J, Klein R, Azen S, Varma R. Smoking, alcohol intake, estrogen use, and age-related macular degeneration in Latinos: The Los Angeles Latino Eye Study. Am J Ophthalmol Jan, 2006; 141(1)79–87
   PubMed Web of Science ®Google Scholar
• Tanko L B, Christiansen C. An update on the antiestrogenic effect of smoking: A literature review with implications for researchers and practitioners. Menopause 2004; 11(1)104–109
   PubMed Web of Science ®Google Scholar
• Klein R, Davis M D, Magli Y L, et al. The Wisconsin Age-Related Maculopathy Grading System. Ophthalmology 1991; 98(7)1128–1134
   PubMed Web of Science ®Google Scholar
• Klein R, Klein B E, Jensen S C, Mares-Perlman J A, Cruickshanks K J, Palta M. Age-related maculopathy in a multiracial United States population: The National Health and Nutrition Examination Survey III. Ophthalmology 1999; 106(6)1056–1065
   PubMed Web of Science ®Google Scholar
• Klein R, Klein B E, Jensen S C, Cruickshanks K J. The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmol 1998; 116: 506–513
   PubMedGoogle Scholar
• Rubin D B. Multiple Imputation for Nonresponse in Surveys. John Wiley & Sons Inc, New York 1987
   Google Scholar
• Schafer J L. Analysis of Incomplete Multivariate Data. Chapman and Hall/CRC, New York 1997
   Google Scholar
• Defay R, Pinchinat S, Lumbroso S, Sutan C, Delcourt C, Pola Study Group. Sex steroids and age-related macular degeneration in older French women: The POLA study. Ann Epidemiol 2004; 14(3)202–208
   Google Scholar
• Seitzman R L, Mangione C M, Cauley J A, Ensrud K E, Stone K L, Cummings S R, Hochberg M C, Hillier T A, Yu F, Coleman A L, Study of Osteoporotic Fractures Research Group. Bone mineral density and age-related maculopathy in older women. J Am Geriatr Soc 2007; 55(5)740–6
   Google Scholar
• Jensen J, Christiansen C, Rødbro P. Cigarette smoking, serum estrogens, and bone loss during hormone replacement therapy early after menopause. N Engl J Med 1985; 313: 973–975
   PubMed Web of Science ®Google Scholar
• Jensen J, Christiansen C. Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy. Am J Obstet Gynecol 1988; 159: 820–825
   PubMed Web of Science ®Google Scholar
• Geisler J, Omsjo I H, Helle S I, Ekse D, Silsand T, Lonning P E. Plasma estrogen fractions in postmenopausal women receiving hormone replacement therapy: Influence of route of administration and cigarette smoking. J Endocrinol 1999; 162: 265–270
   PubMed Web of Science ®Google Scholar
• Cassidenti D L, Vijod A G, Vijod M A, Stanczyk F Z, Lobo R A. Short-term effects of smoking on the pharmacokinetic profiles of micronized estradiol in postmenopausal women. Am J Obstet Gynecol 1990; 163: 1953–1960
   PubMed Web of Science ®Google Scholar
• Bjarnason N H, Christiansen C. The influence of thinness and smoking on bone loss and response to hormone replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 2000; 85: 590–596
   PubMed Web of Science ®Google Scholar
• Kiel D P, Baron J A, Anderson J J, Hannan M T, Felson D T. Smoking eliminates the protective effect of oral estrogens on the risk for hip fracture among women. Ann Intern Med 1992; 116: 716–721
   PubMed Web of Science ®Google Scholar